Species differences in the hepatic biotransformation of zearalenone

Veterinary Journal

Volumn 172, Issue 1, 2006, Pages 96-102

  Malekinejad, H ^a   Maas Bakker, R ^a   Fink Gremmels, J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Zearalenol ( ZOL); Zearalenol ( ZOL); Biotransformation; Glucuronidation; Zearalenone

Indexed keywords

ALPHA ZEARALENOL; BETA ZEARALENOL; DRUG METABOLITE; GLUCURONIC ACID; GLUCURONOSYLTRANSFERASE; ZEARALENONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATTLE; CELL FRACTIONATION; CHICKEN; CONTROLLED STUDY; DOMESTIC ANIMAL; DRUG EXPOSURE; DRUG GLUCURONIDATION; DRUG HYDROXYLATION; DRUG TRANSFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MITOCHONDRION; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; SHEEP; SPECIES DIFFERENCE; SWINE;

ANIMAL FEED; ANIMALS; BIOTRANSFORMATION; CATTLE; CHICKENS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS, NON-STEROIDAL; FOOD CONTAMINATION; LIVER; RATS; SHEEP; SPECIES SPECIFICITY; SWINE; ZEARALENONE;

ANIMALIA; BOS TAURUS; FUSARIUM; GALLUS GALLUS; OVIS ARIES; SUS SCROFA;

EID: 33744915539     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2005.03.004     Document Type: Article

References (34)

1. Belanger A., Couture J., Caron S., and Roy R. Determination of non-conjugated and conjugated steroid levels in plasma and prostrate after separation on C-18 columns. Annals of the New York Academy of Sciences 595 (1990) 251-259
2. Biehl M.L., Prelusky D.B., Koritz G.D., Hartin K.E., Buck W.B., and Trenholm H.L. Biliary excretion and enterohepatic cycling of zearalenone in immature pigs. Toxicology and Applied Pharmacology 121 (1993) 152-159
3. Bories G.F., Perdu-Durand E.F., Sutra J.F., and Tulliez J.E. Evidence for glucuronidation and sulfation of zeranol and metabolites (taleranol and zearalenone) by rat and pig hepatic subfractions. Drug Metabolism and Disposition 19 (1991) 140-143
4. Boyd P.A., and Wittliff J.L. Mechanism of Fusarium mycotoxin action in mammary gland. Journal of Toxicology and Environmental Health 4 (1978) 1-8
5. Celius T., Haugen T.B., Grotmol T., and Walther B.T. A sensitive zonagenetic assay for rapid in vitro assessment of oestrogenic potency of xenobiotics and mycotoxins. Environmental Health Perspectives 107 (1999) 63-68
6. Chang K., Kurtz H.J., and Mirocha C.J. Effects of the mycotoxin zearalenone on swine reproduction. American Journal of Veterinary Research 40 (1979) 1260-1267
7. Degtiar W.G., and Kushlinsky N.E. 3α-Hydroxysteroid dehydrogenase in animal and human tissues. Biochemistry (Moscow) 66 (2001) 256-266
8. Etienne M., and Jemmali M. Effects of zearalenone (F2) on oestrous activity and reproduction in gilts. Journal of Animal Science 55 (1982) 1-10
9. Fink-Gremmels J., and van Miert A.S. Veterinary drugs: disposition, biotransformation and risk evaluation. Analyst 119 (1994) 2521-2528
10. Fitzpatrick D.W., Picken C.A., Murphy L.C., and Buhr M.M. Measurement of the relative binding affinity of zearalenone, α-zearalenol and β-zearalenol for uterine and oviduct oestrogen receptors in swine, rats and chickens: an indicator of oestrogenic potencies. Comparative Biochemistry and Physiology. C. Pharmacology, Toxicology and Endocrinology 94 (1989) 691-694
11. Green M.L., Diekman M.A., Malayer J.R., Scheidt A.B., and Long G.G. Effect of prepubertal consumption of zearalenone on puberty and subsequent reproduction of gilts. Journal of Animal Science 68 (1990) 171-178
12. Katzenellenbogen B.S., Katzenellenbogen J.A., and Mordecai D. Zearalenones: characterization of the oestrogenic potencies and receptor interactions of a series of fungal rbeta-resorcylic acid lactones. Endocrinology 105 (1979) 33-40
13. Kollarczik B., Gareis M., and Hanelt M. In vitro transformation of the Fusarium mycotoxins deoxynivalenol and zearalenone by the normal gut microflora of pigs. Natural Toxins 2 (1994) 105-110
14. Kuiper-Goodman T., Scott P.M., and Watanabe H. Risk assessment of the mycotoxin zearalenone. Regulatory Toxicology and Pharmacology 7 (1987) 253-306
15. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
16. Mirocha C.J., Pathre S.V., and Robison T.S. Comparative metabolism of zearalenone and transmission into bovine milk. Food and Cosmetics Toxicology 19 (1981) 25-30
17. Nebbia C. Biotransformation enzymes as determinants of xenobiotic toxicity in domestic animals. Veterinary Journal 161 (2001) 238-252
18. Olsen M., and Kiessling K.H. Species differences in zearalenone-reducing activity in subcellular fractions of liver from female domestic animals. Acta Pharmacology and Toxicology (Copenhagen) 52 (1983) 287-291
19. Olsen M., Pettersson H., and Kiessling K.H. Reduction of zearalenone to zearalenol in female rat liver by 3α-hydroxysteroid dehydrogenase. Acta Pharmacology and Toxicology (Copenhagen) 48 (1981) 157-161
20. Payne A.H., Abbaszade I.G., Clarke T.R., Bain P.A., and Park C.H. The multiple murine 3 β-hydroxysteroid dehydrogenase isoforms: structure, function, and tissue- and developmentally specific expression. Steroids 62 (1997) 169-175
21. Penning T.M., Bennett M.J., Smith-Hoog S., Schlegel B.P., Jez J.M., and Lewis M. Structure and function of 3α-hydroxysteroid dehydrogenase. Steroids 62 (1997) 101-111
22. Penning T.M., Jin Y., Steckelbroeck S., Lanisnik Rizner T., and Lewis M. Structure-function of human 3α-hydroxysteroid dehydrogenases: genes and proteins. Molecular and Cellular Endocrinology 215 (2004) 63-72
23. Pirog E.C., and Collins D.C. Metabolism of dihydrotestosterone in human liver: importance of 3α- and 3β-hydroxysteroid dehydrogenase. Journal of Clinical Endocrinology and Metabolism 84 (1999) 3217-3221
24. Pompa G., Montesissa C., Di Lauro F.M., and Fadini L. The metabolism of zearalenone in subcellular fractions from rabbit and hen hepatocytes and its oestrogenic activity in rabbits. Toxicology 42 (1986) 69-75
25. Rutten A.A., Falke H.E., Catsburg J.F., Topp R., Blaauboer B.J., van Holsteijn I., Doorn L., and van Leeuwen F.X. Interlaboratory comparison of total cytochrome P-450 and protein determinations in rat liver microsomes. Reinvestigation of assay conditions. Archives of Toxicology 61 (1987) 27-33
26. Schollenberger M., Terry Jara H., Suchy S., Drochner W., and Mueller H.-M. A survey of Fusarium toxins in cereal-based foods marketed in an area of southwest Germany. Mycopathologia 147 (1999) 49-57
27. Shier W.T., Shier A.C., Xie W., and Mirocha C.J. Structure-activity relationships for human oestrogenic activity in zearalenone mycotoxins. Toxicon 39 (2001) 1435-1438
28. Snawder J.E., and Lipscomb J.C. Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment. Regulatory Toxicology and Pharmacology 32 (2000) 200-209
29. Steckelbroeck S., Jin Y., Gopishetty S., Oyesanmi B., and Penning T.M. Human cytosolic 3α-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3β-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. The Journal of Biological Chemistry 279 (2004) 10784-10795
30. Thomas J.L., Duax W.L., Addlagatta A., Kacsoh B., Brandt S.E., and Norris W.B. Structure/function aspects of human 3β-hydroxysteroid dehydrogenase. Molecular and Cellular Endocrinology 215 (2004) 73-82
31. Tukey R.H., and Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annual Review of Pharmacology and Toxicology 40 (2000) 581-616
32. Ueno Y., and Tashiro F. α-zearalenol, a major hepatic metabolite in rats of zearalenone, an oestrogenic mycotoxin of Fusarium species. Journal of Biochemistry (Tokyo) 89 (1981) 563-571
33. Visser T.J., Kaptein E., van Raaij J.A., Joe C.T., Ebner T., and Burchell B. Multiple UDP-glucuronyltransferases for the glucuronidation of thyroid hormone with preference for 3,3′,5′-triiodothyronine (reverse T3). FEBS Letters 315 (1993) 65-68
34. Wood G.E. Mycotoxins in foods and feeds in the United States. Journal of Animal Science 70 (1992) 3941-3949